Vivani Medical
VANI
50 hedge funds and large institutions have $24M invested in Vivani Medical in 2015 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 4 reducing their positions, and 5 closing their positions.
550% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 4
220% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 5
103% more capital invested
Capital invested by funds: $11.9M → $24M (+$12.2M)
28% more funds holding
Funds holding: 39 → 50 (+11)
63% less call options, than puts
Call options by funds: $2.32M | Put options by funds: $6.34M
Top Buyers
Top Sellers
| 1 |
Squarepoint
New York
|
-$244K |
| 2 |
Goldman Sachs
New York
|
-$158K |
| 3 |
AC
Ascend Capital
Orinda,
California
|
-$128K |
| 4 |
HCS
Harvest Capital Strategies
San Francisco,
California
|
-$73.8K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$64K |
VANI Hedge Fund Activity: Q2 2015 in Review
50 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q2 2015, worth a combined $24M — up 103% from $11.9M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new VANI positions and 5 closed out — a net gain of 11 holders — while 26 added to existing stakes and 4 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $2.55M. The largest seller was Squarepoint, exiting entirely with an estimated $244K sold.
- 50 institutional investors held Vivani Medical (VANI) as of Q2 2015, up from 39 in Q1 2015.
- Funds reported $24M of Vivani Medical stock for Q2 2015, up 103% quarter-over-quarter.
- 16 funds opened new Vivani Medical positions in Q2 2015 and 5 closed out, a net change of +11 holders.
- The largest Vivani Medical buyer in Q2 2015 was BlackRock Fund Advisors, an estimated $2.55M added.
- The largest Vivani Medical seller in Q2 2015 was Squarepoint, an estimated $244K sold.
Based on aggregated 13F filings for Q2 2015.